Start Date
January 31, 2024
Primary Completion Date
December 31, 2024
Study Completion Date
March 31, 2025
Amustaline/GSH pathogen reduction technology
Whole blood treated with pathogen reduction technology
Standard of Care
Red Blood Cell Component or whole blood
Collaborators (1)
Cerus Corporation
INDUSTRY
Swiss Transfusion SRC
OTHER